BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HS-IT101 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of HS-IT101\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07105176-2521@assetmemo.bio
DTSTAMP:20261121T004549Z
DTSTART;VALUE=DATE:20270830
DTEND;VALUE=DATE:20270831
SUMMARY:HS-IT101: Phase 1 readout est. (NCT07105176)
DESCRIPTION:HS-IT101\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: HS-IT1
 01 Injection for Advanced NSCLC(FASTIL-Lung01)\nEstimated primary completi
 on: 30 August 2027. This is a ClinicalTrials.gov estimate\, not a confirme
 d readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/h
 s-it101#upcoming-events\nRegistry record: https://clinicaltrials.gov/study
 /NCT07105176
URL:https://assetmemo.bio/drug/hs-it101#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07406724-2521@assetmemo.bio
DTSTAMP:20261121T004549Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:HS-IT101: Phase 2 readout est. (NCT07406724)
DESCRIPTION:HS-IT101\, phase 2\, Melanoma.\nStudy: HS-IT101 Injection Versu
 s Chemotherapy in the Treatment of Advanced Melanoma（FASTIL-Mela02）\nE
 stimated primary completion: 31 December 2027. This is a ClinicalTrials.go
 v estimate\, not a confirmed readout date\, and it can move.\nDrug page: h
 ttps://assetmemo.bio/drug/hs-it101#upcoming-events\nRegistry record: https
 ://clinicaltrials.gov/study/NCT07406724
URL:https://assetmemo.bio/drug/hs-it101#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07770802-2521@assetmemo.bio
DTSTAMP:20261121T004549Z
DTSTART;VALUE=DATE:20280831
DTEND;VALUE=DATE:20280901
SUMMARY:HS-IT101: Phase 1 readout est. (NCT07770802)
DESCRIPTION:HS-IT101\, phase 1\, Clear Cell Renal Cell Carcinoma.\nStudy: C
 linical Study of HS-IT101 Injection in the Treatment of Advanced Renal Can
 cer(FASTIL-Renal01)\nEstimated primary completion: August 2028. This is a 
 ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can mo
 ve.\nDrug page: https://assetmemo.bio/drug/hs-it101#upcoming-events\nRegis
 try record: https://clinicaltrials.gov/study/NCT07770802
URL:https://assetmemo.bio/drug/hs-it101#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
